Data protection Impressum

Healthcare

Takeda has opened a new CHF 200 million biotechnology facility in Neuchâtel to expand aseptic filling capacity for rare disease therapies.

Takeda inaugurates CHF 200 million biotechnology facility in Neuchâtel

1 December 2025

CHUV has opened a new ambulatory radiology facility in Lausanne to centralize imaging services and modernize its diagnostic infrastructure.

CHUV opens new ambulatory radiology facility to improve patient access and diagnostic capacity

25 November 2025

Distalmotion has raised USD 150 million in Series G financing to accelerate the U.S. expansion of its DEXTER surgical robot.

Distalmotion raises USD 150 million to scale its DEXTER surgical robot in the United States

19 November 2025

LEM Surgical has completed its first U.S. clinical procedures using the Dynamis Robotic Surgical System.

Bern’s LEM Surgical completes first U.S. clinical procedures with its Dynamis robotic system

19 November 2025

Renens-based medtech start-up Autonomyo has secured EUR 1.4 million from public and private investors to accelerate the development of its home rehabilitation technologies.

Autonomyo launches crowdfunding to scale home-based robotic rehabilitation

17 November 2025

The Foundation for Innovation and Technology (FIT) has awarded new funding to four start-ups developing high-impact digital and cleantech solutions in Western Switzerland.

Vaud-based start-ups to accelerate innovation in sustainability, health, sport and finance

11 November 2025

Neurotechnology company ONWARD Medical extends its cash runway through 2026 and prepares to expand commercialization and clinical development of its ARC Therapy systems.

ONWARD Medical raises over EUR 50 million to advance spinal cord therapies

27 October 2025

Adaptyv raises USD 8 million to accelerate AI-powered protein validation

27 October 2025

Vaud-based FemTech company Aspivix begins commercial rollout in Southern California and New York following strong clinical validation and growing U.S. demand.

Aspivix launches its breakthrough Carevix device in the United States

21 October 2025

Lausanne-based biotech ADC Therapeutics has secured USD 60 million in new financing to expand commercialization of its cancer treatment ZYNLONTA.

ADC Therapeutics raises USD 60 million to strengthen oncology portfolio

21 October 2025

1 2 3 4 5 6 7 8 9 … 22